Release Date: 28/02/20 15:41 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 2.59MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%